Ozempic 0.25-0.5 MG/dose pen 3ML

Ended Awarded

Contract number
SPE2DB25FMTVR
Awardee
Awarding agency
Obligated
$4,540

Award facts

Contract value 100% obligated
$4,539.93 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The federal contract award is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a diabetes medication, to the Defense Logistics Agency (DLA), a defense agency. The $4,539.93 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 23, 2025, with a completion date of June 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support to military healthcare programs through December 2026. The contract is not set aside and is open to all qualified vendors.

Quick answers

Who was awarded contract SPE2DB25FMTVR?

SPE2DB25FMTVR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 23, 2025.

How much is contract SPE2DB25FMTVR worth?

The government has obligated $4,540 on SPE2DB25FMTVR.

Is contract SPE2DB25FMTVR an order under another contract?

Yes. SPE2DB25FMTVR is a delivery order under SPE2DB20D2104, an indefinite delivery contract.

Was contract SPE2DB25FMTVR competed?

The extent of competition for SPE2DB25FMTVR was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award